Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Dahua Weiye Pharmaceutical is a China-based manufacturer and exporter specializing in pharmaceutical intermediates, fine chemicals, and active pharmaceutical ingredients (APIs). The company's product portfolio includes a diverse range of substances such as local anesthetics, steroid hormones, and various organic synthesis intermediates. Operating out of Wuhan, Hubei province, they serve a global clientele by providing bulk chemical supplies for pharmaceutical research and industrial applications. Their capabilities encompass large-scale chemical synthesis and quality control processes designed to meet international trade standards. The firm is a prominent supplier on major global B2B platforms, focusing on the wholesale distribution of chemical powders and liquids.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Dahua Weiye Pharmaceutical.